TY - JOUR
T1 - ELOVL5 mutations cause spinocerebellar ataxia 38
AU - Di Gregorio, Eleonora
AU - Borroni, Barbara
AU - Giorgio, Elisa
AU - Lacerenza, Daniela
AU - Ferrero, Marta
AU - Lo Buono, Nicola
AU - Ragusa, Neftj
AU - Mancini, Cecilia
AU - Gaussen, Marion
AU - Calcia, Alessandro
AU - Mitro, Nico
AU - Hoxha, Eriola
AU - Mura, Isabella
AU - Coviello, Domenico A.
AU - Moon, Young Ah
AU - Tesson, Christelle
AU - Vaula, Giovanna
AU - Couarch, Philippe
AU - Orsi, Laura
AU - Duregon, Eleonora
AU - Papotti, Mauro Giulio
AU - Deleuze, Jean François
AU - Imbert, Jean
AU - Costanzi, Chiara
AU - Padovani, Alessandro
AU - Giunti, Paola
AU - Maillet-Vioud, Marcel
AU - Durr, Alexandra
AU - Brice, Alexis
AU - Tempia, Filippo
AU - Funaro, Ada
AU - Boccone, Loredana
AU - Caruso, Donatella
AU - Stevanin, Giovanni
AU - Brusco, Alfredo
N1 - Funding Information:
We are grateful to all family members who contributed to this study and to Fanny Mochel and Foudil Lamari for helpful discussions. We thank C. Castagnoli (Città della Salute e della Scienza, Torino) and G. Matullo (Hugef Foundation, Torino) for providing control cell lines and R. Sitia (Ospedale San Raffaele - Milano) for providing anti-calreticulum, anti-ERGIC-53/p58, and anti-GM130 antibodies. The Galliera Genetic Bank of the Telethon Network of Genetic Biobanks (project GTB12001), funded by Telethon Italy, provided us with specimens. This work was funded by the Associazione Italiana Sindromi Atassiche, the Associazione E.E. Rulfo per la Genetica Medica, PRIN 2010_2011 project 20108WT59Y (to A. Brusco), the GIS - Institut des Maladies Rares (A10021DS to G.S.), the Agence Nationale de la Recherche (SPATAX-Quest project to G.S.), the European Commission Seventh Framework Programme (E12009DD [Neuromics] and E04006DD [EUROSCA] to A. Brice), the program “Investissements d’Avenir” ANR-10-IAIHU-06 (to the Institut du Cerveau et de la Moelle Épinière), the Verum Foundation (to A. Brice and G.S.), and the Fondation Roger de Spoelberch (R12123DD to A. Brice). We thank Jay D. Horton (SouthWestern University, Dallas) for comments and critical discussion of the manuscript.
PY - 2014/8/7
Y1 - 2014/8/7
N2 - Spinocerebellar ataxias (SCAs) are a heterogeneous group of autosomal-dominant neurodegenerative disorders involving the cerebellum and 23 different genes. We mapped SCA38 to a 56 Mb region on chromosome 6p in a SCA-affected Italian family by whole-genome linkage analysis. Targeted resequencing identified a single missense mutation (c.689G>T [p.Gly230Val]) in ELOVL5. Mutation screening of 456 independent SCA-affected individuals identified the same mutation in two further unrelated Italian families. Haplotyping showed that at least two of the three families shared a common ancestor. One further missense variant (c.214C>G [p.Leu72Val]) was found in a French family. Both missense changes affect conserved amino acids, are predicted to be damaging by multiple bioinformatics tools, and were not identified in ethnically matched controls or within variant databases. ELOVL5 encodes an elongase involved in the synthesis of polyunsaturated fatty acids of the ω3 and ω6 series. Arachidonic acid and docosahexaenoic acid, two final products of the enzyme, were reduced in the serum of affected individuals. Immunohistochemistry on control mice and human brain demonstrated high levels in Purkinje cells. In transfection experiments, subcellular localization of altered ELOVL5 showed a perinuclear distribution with a signal increase in the Golgi compartment, whereas the wild-type showed a widespread signal in the endoplasmic reticulum. SCA38 and SCA34 are examples of SCAs due to mutations in elongase-encoding genes, emphasizing the importance of fatty-acid metabolism in neurological diseases.
AB - Spinocerebellar ataxias (SCAs) are a heterogeneous group of autosomal-dominant neurodegenerative disorders involving the cerebellum and 23 different genes. We mapped SCA38 to a 56 Mb region on chromosome 6p in a SCA-affected Italian family by whole-genome linkage analysis. Targeted resequencing identified a single missense mutation (c.689G>T [p.Gly230Val]) in ELOVL5. Mutation screening of 456 independent SCA-affected individuals identified the same mutation in two further unrelated Italian families. Haplotyping showed that at least two of the three families shared a common ancestor. One further missense variant (c.214C>G [p.Leu72Val]) was found in a French family. Both missense changes affect conserved amino acids, are predicted to be damaging by multiple bioinformatics tools, and were not identified in ethnically matched controls or within variant databases. ELOVL5 encodes an elongase involved in the synthesis of polyunsaturated fatty acids of the ω3 and ω6 series. Arachidonic acid and docosahexaenoic acid, two final products of the enzyme, were reduced in the serum of affected individuals. Immunohistochemistry on control mice and human brain demonstrated high levels in Purkinje cells. In transfection experiments, subcellular localization of altered ELOVL5 showed a perinuclear distribution with a signal increase in the Golgi compartment, whereas the wild-type showed a widespread signal in the endoplasmic reticulum. SCA38 and SCA34 are examples of SCAs due to mutations in elongase-encoding genes, emphasizing the importance of fatty-acid metabolism in neurological diseases.
UR - http://www.scopus.com/inward/record.url?scp=84905916269&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84905916269&partnerID=8YFLogxK
U2 - 10.1016/j.ajhg.2014.07.001
DO - 10.1016/j.ajhg.2014.07.001
M3 - Article
C2 - 25065913
AN - SCOPUS:84905916269
SN - 0002-9297
VL - 95
SP - 209
EP - 217
JO - American Journal of Human Genetics
JF - American Journal of Human Genetics
IS - 2
ER -